Moller-Olsen, C., Ho, S.F.S., Shukla, R.D., Feher, T. and Sagona, A.P. (2018) Engineered K1F Bacteriophages Kill Intracellular Escherichia coli K1 in Human Epithelial Cells. Scientific Reports, 8, Article No. 17559.
https://doi.org/10.1038/s41598-018-35859-6

has been cited by the following article:

• TITLE: Bacterial and Viral Therapies of Cancer: Background, Mechanism and Perspective

  AUTHORS: Qinglin Dong, Xiangying Xing

  KEYWORDS: Cancer Therapy, Protist, Bacteria, Viruses, Bacteriophage, Responsive Cancer Antigen

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.9 No.7, July 21, 2021

  ABSTRACT: Bacterial and viral therapies of cancer are highly promising, yet their mechanisms are incompletely understood, hindering their improvement and application. In this paper, We 1) review briefly the genesis and progress of bacterial and viral therapies of cancer; 2) compare and evaluate the proposed mechanisms of bacterial and viral therapies of cancer and present the unifying mechanism that bacteria/viruses stimulate cancer cells to produce antibacterial/antiviral proteins, which also serve as the responsive cancer antigens triggering host anticancer immune response; and 3) provide a perspective on the exploitation of non-human and non-animal bacteria and viruses and other microorganisms, particularly protist-infecting bacteria and viruses and bacterial/cyanobacterial viruses (bacteriophage/phage and cyanophage), for cancer treatment and prevention.